Ulisse Biomed S.p.A. (BIT: UBM)
Italy
· Delayed Price · Currency is EUR 0.950
+0.044 (4.86%)
Jan 17, 2025, 5:35 PM CET
Ulisse Biomed Revenue
Ulisse Biomed had revenue of 370.86K EUR in the half year ending June 30, 2024, with 482.47% growth. This brings the company's revenue in the last twelve months to 420.92K, up 363.03% year-over-year. In the year 2023, Ulisse Biomed had annual revenue of 66.21K, down -52.17%.
Revenue (ttm)
420.92K
Revenue Growth
+363.03%
P/S Ratio
49.21
Revenue / Employee
52.62K
Employees
10
Market Cap
21.13M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.27B |
| Amplifon | 2.36B |
| DiaSorin | 1.18B |
| EL.En. | 665.50M |
| Philogen | 3.92M |
| Pharmanutra | 113.13M |
| Safilo Group | 1.01B |
| GPI S.p.A. | 484.01M |